Favipiravir
- Generic Name
- Favipiravir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C5H4FN3O2
- CAS Number
- 259793-96-9
- Unique Ingredient Identifier
- EW5GL2X7E0
- Background
Discovered by Toyama Chemical Co., Ltd. in Japan, favipiravir is a modified pyrazine analog that was initially approved for therapeutic use in resistant cases of influenza. The antiviral targets RNA-dependent RNA polymerase (RdRp) enzymes, which are necessary for the transcription and replication of viral genomes.
...
- Indication
⑴用于埃博拉病毒感染的治疗。
⑵用于治疗成人新型或再次流行的流感（仅限于其他抗流感病毒药物治疗无效或效果不佳时使用）
- Associated Conditions
- Treatment resistant Novel Influenza, Treatment resistant Reemerging Influenza
- Associated Therapies
- -
Efficacy of Favipiravir Against Ebola (JIKI)
- First Posted Date
- 2014-12-31
- Last Posted Date
- 2016-11-15
- Target Recruit Count
- 126
- Registration Number
- NCT02329054
- Locations
- 🇬🇳
The caregivers treatment center, Conakry, Guinea
🇬🇳ALIMA Ebola care center, Nzerekore, Guinea
🇬🇳MSF Ebola treatment centre, Gueckedou, Guinea
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316
- First Posted Date
- 2014-01-03
- Last Posted Date
- 2015-11-11
- Lead Sponsor
- MDVI, LLC
- Target Recruit Count
- 860
- Registration Number
- NCT02026349
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults
- First Posted Date
- 2013-12-11
- Last Posted Date
- 2015-11-11
- Lead Sponsor
- MDVI, LLC
- Target Recruit Count
- 1161
- Registration Number
- NCT02008344
T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza
- First Posted Date
- 2012-11-20
- Last Posted Date
- 2015-10-21
- Lead Sponsor
- MDVI, LLC
- Target Recruit Count
- 550
- Registration Number
- NCT01728753
- Locations
- 🇺🇸
Miami Research Associates, Miami, Florida, United States
Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment
- First Posted Date
- 2011-08-18
- Last Posted Date
- 2015-10-22
- Lead Sponsor
- MDVI, LLC
- Target Recruit Count
- 36
- Registration Number
- NCT01419457
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸Orlando Clinical Research Center, Orlando, Florida, United States
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza
- First Posted Date
- 2010-02-15
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- MDVI, LLC
- Target Recruit Count
- 530
- Registration Number
- NCT01068912
- Locations
- 🇺🇸
#048, Elkridge, Maryland, United States
🇺🇸#132, Houston, Texas, United States
🇺🇸#157, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.